The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 22, 2026 | Coulie Bernard | President and CEO, Director | Grant(A) | 1.2M | — | $0 |
| Jan 22, 2026 | Cheung Lily | Chief Human Resource Officer | Grant(A) | 300K | — | $0 |
| Jan 22, 2026 | Kuo Minnie | Chief Operating Officer | Grant(A) | 300K | — | $0 |
| Jan 22, 2026 | Cummings Keith Lamont | Chief Financial Officer | Grant(A) | 400K | — | $0 |
| Jan 20, 2026 | Kuo Minnie | Chief Operating Officer | Sell(S) | 7K | $1.28 | $9K |
| Jan 20, 2026 | Coulie Bernard | President and CEO, Director | Sell(S) | 89K | $1.28 | $114K |
| Jan 20, 2026 | Cheung Lily | Chief Human Resource Officer | Sell(S) | 8K | $1.28 | $10K |
| Jan 20, 2026 | Cummings Keith Lamont | Chief Financial Officer | Sell(S) | 24K | $1.28 | $31K |
| Jun 5, 2025 | Crowell Gayle A | Director | Grant(A) | 30K | — | $0 |
| Jun 5, 2025 | Huh Hoyoung | Director | Grant(A) | 30K | — | $0 |
| Jun 5, 2025 | Pyott David E I | Director | Grant(A) | 30K | — | $0 |
| Jun 5, 2025 | Cline Darren S | Director | Grant(A) | 30K | — | $0 |
| Jun 5, 2025 | Krognes Steve E. | Director | Grant(A) | 30K | — | $0 |
| Jun 5, 2025 | Curnutte John T | Director | Grant(A) | 30K | — | $0 |
| Jun 5, 2025 | MCCOURT Thomas A | Director | Grant(A) | 30K | — | $0 |
| Jun 5, 2025 | Knobil Katharine | Director | Grant(A) | 30K | — | $0 |
| Jun 5, 2025 | Bruhn Suzanne Louise | Director | Grant(A) | 30K | — | $0 |
| Jan 23, 2025 | Coulie Bernard | President and CEO, Director | Grant(A) | 163K | — | $0 |
| Jan 23, 2025 | Coulie Bernard | President and CEO, Director | Grant(A) | 325K | — | $0 |
| Jan 23, 2025 | Cummings Keith Lamont | Chief Financial Officer | Grant(A) | 57K | — | $0 |
| Jan 23, 2025 | Cummings Keith Lamont | Chief Financial Officer | Grant(A) | 113K | — | $0 |
| Jan 23, 2025 | Lefebvre Eric | Chief Medical Officer | Grant(A) | 46K | — | $0 |
| Jan 23, 2025 | Lefebvre Eric | Chief Medical Officer | Grant(A) | 91K | — | $0 |
| Jan 23, 2025 | Hull Hans | Chief Business Officer | Grant(A) | 40K | — | $0 |
| Jan 23, 2025 | Hull Hans | Chief Business Officer | Grant(A) | 80K | — | $0 |
| Jan 23, 2025 | Ouimette Mike | General Counsel & Corp. Sec'y | Grant(A) | 35K | — | $0 |
| Jan 23, 2025 | Ouimette Mike | General Counsel & Corp. Sec'y | Grant(A) | 70K | — | $0 |
| Jan 23, 2025 | Cheung Lily | Chief Human Resource Officer | Grant(A) | 26K | — | $0 |
| Jan 23, 2025 | Cheung Lily | Chief Human Resource Officer | Grant(A) | 52K | — | $0 |
| Jan 22, 2025 | Ouimette Mike | General Counsel & Corp. Sec'y | Sell(S) | 10K | $10.99 | $112K |
| Jan 17, 2025 | Ouimette Mike | General Counsel & Corp. Sec'y | Sell(S) | 13K | $11.20 | $149K |
| Jan 17, 2025 | Cheung Lily | Chief Human Resource Officer | Sell(S) | 4K | $11.20 | $42K |
| Jan 17, 2025 | Lefebvre Eric | Chief Medical Officer | Sell(S) | 18K | $11.20 | $207K |
| Jan 17, 2025 | Hull Hans | Chief Business Officer | Sell(S) | 16K | $11.20 | $178K |
| Jan 17, 2025 | Cummings Keith Lamont | Chief Financial Officer | Sell(S) | 20K | $11.20 | $226K |
| Jan 17, 2025 | Coulie Bernard | President and CEO, Director | Sell(S) | 52K | $11.20 | $587K |
| Jul 10, 2024 | Ouimette Mike | General Counsel & Corp. Sec'y | Sell(S) | 8K | $11.56 | $89K |
| Jul 10, 2024 | Coulie Bernard | President and CEO, Director | Sell(S) | 39K | $11.56 | $447K |
| Jul 10, 2024 | Cummings Keith Lamont | Chief Financial Officer | Sell(S) | 11K | $11.56 | $126K |
| Jul 10, 2024 | Hull Hans | Chief Business Officer | Sell(S) | 10K | $11.56 | $114K |
| Jul 10, 2024 | Lefebvre Eric | Chief Medical Officer | Sell(S) | 12K | $11.56 | $142K |
| Jul 9, 2024 | Ouimette Mike | General Counsel & Corp. Sec'y | Grant(A) | 15K | — | $0 |
| Jul 9, 2024 | Coulie Bernard | President and CEO, Director | Grant(A) | 76K | — | $0 |
| Jul 9, 2024 | Cummings Keith Lamont | Chief Financial Officer | Grant(A) | 21K | — | $0 |
| Jul 9, 2024 | Hull Hans | Chief Business Officer | Grant(A) | 19K | — | $0 |
| Jul 9, 2024 | Lefebvre Eric | Chief Medical Officer | Grant(A) | 24K | — | $0 |
| Jun 13, 2024 | Krognes Steve E. | Director | Grant(A) | 54K | — | $0 |
| Jun 13, 2024 | Curnutte John T | Director | Grant(A) | 27K | — | $0 |
| Jun 13, 2024 | Bruhn Suzanne Louise | Director | Grant(A) | 27K | — | $0 |
| Jun 13, 2024 | Crowell Gayle A | Director | Grant(A) | 27K | — | $0 |
| Jun 13, 2024 | Cline Darren S | Director | Grant(A) | 27K | — | $0 |
| Jun 13, 2024 | Shah Smital | Director | Grant(A) | 27K | — | $0 |
| Jun 13, 2024 | Pyott David E I | Director | Grant(A) | 27K | — | $0 |
| Jun 13, 2024 | Huh Hoyoung | Director | Grant(A) | 27K | — | $0 |
| Jun 13, 2024 | Knobil Katharine | Director | Grant(A) | 27K | — | $0 |
| Jun 13, 2024 | MCCOURT Thomas A | Director | Grant(A) | 27K | — | $0 |
| May 2, 2024 | Cummings Keith Lamont | Chief Financial Officer | Option exercise(M) | 21K | $2.08 | $44K |
| May 2, 2024 | Cummings Keith Lamont | Chief Financial Officer | Option exercise(M) | 21K | — | $0 |
| Jan 23, 2024 | Coulie Bernard | President and CEO, Director | Grant(A) | 128K | — | $0 |
| Jan 23, 2024 | Coulie Bernard | President and CEO, Director | Grant(A) | 256K | — | $0 |
| Jan 23, 2024 | Cheung Lily | Chief Human Resource Officer | Grant(A) | 26K | — | $0 |
| Jan 23, 2024 | Cheung Lily | Chief Human Resource Officer | Grant(A) | 52K | — | $0 |
| Jan 23, 2024 | Cummings Keith Lamont | Chief Financial Officer | Grant(A) | 55K | — | $0 |
| Jan 23, 2024 | Cummings Keith Lamont | Chief Financial Officer | Grant(A) | 111K | — | $0 |
| Jan 23, 2024 | Ouimette Mike | General Counsel & Corp. Sec'y | Grant(A) | 32K | — | $0 |
| Jan 23, 2024 | Ouimette Mike | General Counsel & Corp. Sec'y | Grant(A) | 63K | — | $0 |
| Jan 23, 2024 | Hull Hans | Chief Business Officer | Grant(A) | 32K | — | $0 |
| Jan 23, 2024 | Hull Hans | Chief Business Officer | Grant(A) | 63K | — | $0 |
| Jan 23, 2024 | Lefebvre Eric | Chief Medical Officer | Grant(A) | 43K | — | $0 |
| Jan 23, 2024 | Lefebvre Eric | Chief Medical Officer | Grant(A) | 86K | — | $0 |
| Jan 17, 2024 | Ouimette Mike | General Counsel & Corp. Sec'y | Sell(S) | 5K | $17.23 | $90K |
| Jan 17, 2024 | Lefebvre Eric | Chief Medical Officer | Sell(S) | 10K | $17.23 | $177K |
| Jan 17, 2024 | Coulie Bernard | President and CEO, Director | Sell(S) | 26K | $17.23 | $443K |
| Jan 17, 2024 | Hull Hans | Chief Business Officer | Sell(S) | 10K | $17.23 | $169K |
| Jan 17, 2024 | Cummings Keith Lamont | Chief Financial Officer | Sell(S) | 10K | $17.23 | $169K |
| Aug 4, 2023 | Hull Hans | Chief Business Officer | Sell(S) | 20K | $20.01 | $401K |
| Aug 4, 2023 | Hull Hans | Chief Business Officer | Option exercise(M) | 9K | $2.08 | $18K |
| Aug 4, 2023 | Hull Hans | Chief Business Officer | Option exercise(M) | 9K | — | $0 |
| Aug 3, 2023 | Hull Hans | Chief Business Officer | Option exercise(M) | 2K | $2.08 | $4K |
| Aug 3, 2023 | Hull Hans | Chief Business Officer | Sell(S) | 13K | $20.00 | $261K |
| Aug 3, 2023 | Hull Hans | Chief Business Officer | Buy(S) | 2K | $20.00 | $36K |
| Aug 3, 2023 | Hull Hans | Chief Business Officer | Option exercise(M) | 2K | — | $0 |
| Jul 20, 2023 | Ouimette Mike | General Counsel & Corp. Sec'y | Sell(S) | 5K | $17.55 | $83K |
| Jul 17, 2023 | Coulie Bernard | President and CEO, Director | Sell(S) | 70K | $18.01 | $1.3M |
| Jul 17, 2023 | Cummings Keith Lamont | Chief Financial Officer | Sell(S) | 20K | $18.01 | $356K |
| Jul 17, 2023 | Hull Hans | Chief Business Officer | Sell(S) | 18K | $18.01 | $323K |
| Jul 17, 2023 | Lefebvre Eric | Chief Medical Officer | Sell(S) | 22K | $18.01 | $402K |
| Jul 17, 2023 | Ouimette Mike | General Counsel & Corp. Sec'y | Sell(S) | 13K | $18.01 | $230K |
| Jul 14, 2023 | Coulie Bernard | President and CEO, Director | Grant(A) | 138K | — | $0 |
| Jul 14, 2023 | Cummings Keith Lamont | Chief Financial Officer | Grant(A) | 39K | — | $0 |
| Jul 14, 2023 | Hull Hans | Chief Business Officer | Grant(A) | 35K | — | $0 |
| Jul 14, 2023 | Lefebvre Eric | Chief Medical Officer | Grant(A) | 44K | — | $0 |
| Jul 14, 2023 | Ouimette Mike | General Counsel & Corp. Sec'y | Grant(A) | 27K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).